SEC Filing Summary: Becton, Dickinson and Company (BDX)
Business Context and Reporting Period
This Form 8-K, dated August 7, 2025, reports the financial results for Becton, Dickinson and Company's third fiscal quarter ending June 30, 2025. The filing serves as a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Material Changes
The filing does not detail specific material changes versus the prior comparable period. It notes that the referenced press release contains non-GAAP financial measures that differ from U.S. GAAP, with reconciliation details available in the exhibit schedules.
Guidance, Outlook, and Risks
The provided text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. Such information is expected to be found in the full text of the press release (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q3 2025 revenue, earnings per share, and cash flow figures.
- Examine the non-GAAP reconciliation schedules in the press release to understand adjustments to GAAP results.
- Verify any updated full-year guidance or outlook provided in the press release.
- Check for specific commentary on segment performance (Vascular, Surgical, Biosciences) within the exhibit.